Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma emission detection refers to the identification and measurement of gamma rays, which are high-energy photons emitted from atomic nuclei during radioactive decay or nuclear reactions. Gamma rays are highly penetrating electromagnetic radiation and require specialized detectors for their observation and quantification. In medical imaging (e.g., SPECT), radiopharmaceuticals labeled with gamma-emitting isotopes are administered, and their distribution is tracked via the emitted gamma rays. The core principle of gamma emission detection involves converting incoming neutral gamma photons into detectable electrical signals through photoelectric effect, Compton scattering, or pair production. Detector types include scintillation detectors (e.g., NaI(Tl), CsI, BGO) and semiconductor detectors (e.g., HPGe).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma Emission Detection.